Krisja Vermeylen

Director/Board Member bei MORPHOSYS AG

Vermögen: 217 728 $ am 31.03.2024

62 Jahre

87 Beziehungen

Health Technology

Health Services

Consumer Services

Aktive Positionen von Krisja Vermeylen

Unternehmen	Position	Beginn	Ende
MORPHOSYS AG	Director/Board Member	01.01.2017	-
MORPHOSYS AG	Independent Dir/Board Member	01.01.2017	-

Karriereverlauf von Krisja Vermeylen

Ehemalige bekannte Positionen von Krisja Vermeylen

Unternehmen	Position	Beginn	Ende
Diaverum AB Diaverum AB Medical/Nursing ServicesHealth Services Diaverum AB engages in the provision of renal care to patients with chronic kidney disease (CKD). It offers hemodialysis, peritoneal dialysis, and kidney transplant. The company was founded by Nils Alwall in 1991 and is headquartered in Malmo, Sweden.	Director/Board Member	01.09.2020	31.12.2023
NOVO NORDISK A/S	Human Resources Officer	01.01.2015	01.01.2018
Novo Nordisk Pharma GmbH Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany.	Corporate Officer/Principal	01.01.2013	01.01.2015
Novo Nordisk SAS Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France.	Corporate Officer/Principal	01.01.1997	01.01.2013
Novo Nordisk SA (Belgium)	Corporate Officer/Principal	01.01.1998	01.01.2002
Novo Nordisk SA (Belgium)	Sales & Marketing	01.01.1997	01.01.1998
Pharmacia & Upjohn Pharmacia & Upjohn Pharmaceuticals: MajorHealth Technology Pharmacia & Upjohn is a Belgian company that manufactures pharmaceutical products. The private company is based in Brussels, Belgium.	Corporate Officer/Principal	01.01.1993	01.01.1997

Ausbildung von Krisja Vermeylen

University of Antwerp

Graduate Degree

Statistik

International

Belgien	4
Deutschland	3
Dänemark	2

Operativ

Corporate Officer/Principal	4
Director/Board Member	2
Independent Dir/Board Member	1

Sektoral

Health Technology	6
Health Services	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	2
NOVO NORDISK A/S	Health Technology
MORPHOSYS AG	Health Technology

Private Unternehmen	5
Novo Nordisk Pharma GmbH Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany.	Health Technology
Novo Nordisk SAS Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France.	Health Technology
Diaverum AB Diaverum AB Medical/Nursing ServicesHealth Services Diaverum AB engages in the provision of renal care to patients with chronic kidney disease (CKD). It offers hemodialysis, peritoneal dialysis, and kidney transplant. The company was founded by Nils Alwall in 1991 and is headquartered in Malmo, Sweden.	Health Services
Novo Nordisk SA (Belgium)
Pharmacia & Upjohn Pharmacia & Upjohn Pharmaceuticals: MajorHealth Technology Pharmacia & Upjohn is a Belgian company that manufactures pharmaceutical products. The private company is based in Brussels, Belgium.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an